EUVIMEDEUVIMED entdecken
Crossref

Effects of Oral Immunotherapy on the Growth Trajectories of Food-Allergic Children

Matan Elkan, Liat Nachshon, Ortal Cohen, Michael B Levy, Yael Koren, Naama Epstein-Rigby, Arnon Elizur, Michael R Goldberg

The Journal of Allergy and Clinical Immunology: In Practice · 2026

DOI: 10.1016/j.jaip.2025.08.016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Allergy and Clinical Immunology: In Practice, 2026. Verfasst von Matan Elkan und 7 weiteren Autor:innen. Beteiligte Einrichtung: The Institute of Allergy, Immunology, and Pediatric Pulmonary, Shamir Medical Center (Assaf-Harofeh), Zerifin, Israel; Department of Internal Medicin…. Hauptthemen laut MEDLINE: Desensitization, Immunologic, Food Hypersensitivity, Allergens. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Ministry of Health, State of Israel.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Children with IgE-mediated food allergies, particularly milk, are at risk for hampered growth. Limited data are available regarding the benefit of oral immunotherapy (OIT) on growth outcomes. OBJECTIVE: To evaluate the impact of OIT on growth metrics in this population. METHODS: We retrospectively analyzed data from patients (aged 4-15 [females] and 4-16.5 [males] years) who successfully completed OIT. Pre- and post-OIT height-for-age and weight-for-age z-scores (HAZ and WAZ, respectively) were calculated using World Health Organization standards. RESULTS: Patients (n = 458, mean age 8.0 ± 2.7 years) successfully treated for tree nut (33.4%), peanut (29.7%), milk (17.2%), sesame (14.6%), and egg (4.8%) allergy were analyzed. Baseline mean HAZ -0.19 ± 1.05 improved to -0.10 ± 1.05 (P < .001) after OIT (median duration, 19.4 months). This was positively correlated with the mean change in WAZ (r = 0.44, P < .001). Milk-allergic patients had lower baseline HAZ than non-milk-allergic patients (-0.45 ± 0.91 vs -0.14 ± 1.07, P = .016). Patients beginning OIT before age 6 had the greatest HAZ improvement (0.16 ± 0.42), whereas those starting after age 12 experienced a decrease (-0.11 ± 0.49). In 113 patients with a median 34-month follow-up, HAZ improved by 0.30 ± 0.73 (P < .001). This effect was not observed at long-term follow-up in a group of patients who did not achieve successful OIT (n = 21). Using a linear regression model, significant predictors of follow-up HAZ were younger age at baseline (B = -0.09, 95% confidence interval [CI] [-0.15, -0.03], P = .002) and lower baseline HAZ (B = 0.83, 95% CI [0.69, 0.97], P < .001). CONCLUSIONS: OIT may enhance long-term growth in allergic children, especially in younger patients and those with a lower baseline HAZ. Effects on their final stature remain to be determined.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Desensitization, ImmunologicFood HypersensitivityAllergensHumansChildMaleFemaleChild, PreschoolAdolescentRetrospective StudiesAdministration, OralImmunoglobulin ETreatment Outcome

Stichwörter der Autor:innen

Catch-up growthFood allergyOral immunotherapyPediatric growth

Substanzen

AllergensImmunoglobulin E

Autor:innen und Institutionen

  • The Institute of Allergy, Immunology, and Pediatric Pulmonary, Shamir Medical Center (Assaf-Harofeh), Zerifin, Israel; Department of Internal Medicine A, Shamir Medical Center (Assaf-Harofeh), Zerifin, Israel; Departmen…
  • The Institute of Allergy, Immunology, and Pediatric Pulmonary, Shamir Medical Center (Assaf-Harofeh), Zerifin, Israel; Department of Medicine, Gray Faculty of Medical & Health Sciences, Tel-Aviv University, Tel-Aviv, Is…
  • The Institute of Allergy, Immunology, and Pediatric Pulmonary, Shamir Medical Center (Assaf-Harofeh), Zerifin, Israel.
  • The Institute of Allergy, Immunology, and Pediatric Pulmonary, Shamir Medical Center (Assaf-Harofeh), Zerifin, Israel; Department of Pediatrics, Gray Faculty of Medical & Health Sciences, Tel-Aviv University, Tel-Aviv,…

Förderung

  • Ministry of Health, State of Israel

Zitieren

APA

Elkan, M., Nachshon, L., Cohen, O., Levy, M. B., Koren, Y., Epstein-Rigby, N., Elizur, A., & Goldberg, M. R. (2026). Effects of Oral Immunotherapy on the Growth Trajectories of Food-Allergic Children. The Journal of Allergy and Clinical Immunology: In Practice. https://doi.org/10.1016/j.jaip.2025.08.016

Vancouver

Elkan M, Nachshon L, Cohen O, Levy MB, Koren Y, Epstein-Rigby N, et al. Effects of Oral Immunotherapy on the Growth Trajectories of Food-Allergic Children. The Journal of Allergy and Clinical Immunology: In Practice. 2026. doi:10.1016/j.jaip.2025.08.016

BibTeX
@article{Elkan2026,
  author = {Elkan, Matan and Nachshon, Liat and Cohen, Ortal and Levy, Michael B and Koren, Yael and Epstein-Rigby, Naama and Elizur, Arnon and Goldberg, Michael R},
  title = {Effects of Oral Immunotherapy on the Growth Trajectories of Food-Allergic Children},
  journal = {The Journal of Allergy and Clinical Immunology: In Practice},
  year = {2026},
  doi = {10.1016/j.jaip.2025.08.016}
}
Kostenlos starten →